Why Tilray Brands, Inc. (TLRY) Dipped More Than Broader Market Today

18.06.25 00:00 Uhr

Werte in diesem Artikel
Aktien

0,32 EUR -0,01 EUR -3,34%

Tilray Brands, Inc. (TLRY) ended the recent trading session at $0.38, demonstrating a -9.07% change from the preceding day's closing price. The stock's change was less than the S&P 500's daily loss of 0.84%. Elsewhere, the Dow lost 0.7%, while the tech-heavy Nasdaq lost 0.91%. Heading into today, shares of the company had lost 14.65% over the past month, outpacing the Medical sector's loss of 0% and lagging the S&P 500's gain of 1.44%.Investors will be eagerly watching for the performance of Tilray Brands, Inc. in its upcoming earnings disclosure. The company is forecasted to report an EPS of -$0.03, showcasing a 25% upward movement from the corresponding quarter of the prior year. Simultaneously, our latest consensus estimate expects the revenue to be $254.8 million, showing a 10.84% escalation compared to the year-ago quarter. For the annual period, the Zacks Consensus Estimates anticipate earnings of -$1.01 per share and a revenue of $850.75 million, signifying shifts of -206.06% and 0%, respectively, from the last year. Investors might also notice recent changes to analyst estimates for Tilray Brands, Inc. These revisions help to show the ever-changing nature of near-term business trends. As such, positive estimate revisions reflect analyst optimism about the business and profitability. Based on our research, we believe these estimate revisions are directly related to near-term stock moves. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system. The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. The Zacks Consensus EPS estimate remained stagnant within the past month. Currently, Tilray Brands, Inc. is carrying a Zacks Rank of #3 (Hold). The Medical - Products industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 151, which puts it in the bottom 39% of all 250+ industries. The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. To follow TLRY in the coming trading sessions, be sure to utilize Zacks.com. 7 Best Stocks for the Next 30 DaysJust released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."Since 1988, the full list has beaten the market more than 2X over with an average gain of +23.5% per year. So be sure to give these hand picked 7 your immediate attention. See them now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Tilray Brands, Inc. (TLRY): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Tilray (ex Aphria) und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Ausgewählte Hebelprodukte auf Tilray (ex Aphria)

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Tilray (ex Aphria)

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Tilray (ex Aphria)

Wer­bung

Analysen zu Tilray (ex Aphria)

DatumRatingAnalyst
14.08.2019Tilray BuyThe Benchmark Company
05.06.2019Tilray PerformOppenheimer & Co. Inc.
15.05.2019Tilray Market PerformBMO Capital Markets
21.02.2019Aphria BuySeaport Global Securities
21.02.2019Tilray NeutralSeaport Global Securities
DatumRatingAnalyst
14.08.2019Tilray BuyThe Benchmark Company
15.05.2019Tilray Market PerformBMO Capital Markets
21.02.2019Aphria BuySeaport Global Securities
16.10.2018Tilray BuyThe Benchmark Company
DatumRatingAnalyst
05.06.2019Tilray PerformOppenheimer & Co. Inc.
21.02.2019Tilray NeutralSeaport Global Securities
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Tilray (ex Aphria) nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen